NASDAQ: BIIB       Biogen Inc
Last Price Today's Change   Day's Range   Trading Volume
320.885   -2.875 (0.89%)  320.24 - 327.75  381,290


Avg Volume (4 weeks):1,124,710
4 Weeks Range:305.90 - 336.57
4 Weeks Price Volatility (%):
52 Weeks Range:249.17 - 388.67
52 Weeks Price Volatility (%):
Average Price Target: 446.00
Price Target Upside/Downside: +125.115


No recent Headlines for this stock.

Business Background

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

  Be the first to like this.


2360  5281  429  642 

Top 10 Active Counters
 AMD 25.75-0.25 
 SGYP 0.03-0.033 
 TAHO 3.64-0.15 
 NVAX 0.645+0.093 
 CHK 3.30+0.14 
 ACB 9.63-0.33 
 SPY 280.87-1.53 
 F 8.52-0.18 
 NIO 5.82-0.14 
 MTFB 2.84+1.23 
Partners & Brokers